跳至主要内容
临床试验/NCT00467454
NCT00467454撤回2 期

A Double-Blind, Placebo-Controlled Study of Naltrexone in Pyromania

University of Minnesota1 个研究点 分布在 1 个国家开始时间: 2007年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
撤回
试验地点
1
主要终点
Yale Brown Obsessive Compulsive Scale Modified for Pyromania (P-YBOCS)

研究概览

简要总结

The proposed study will consist of 8 weeks of treatment with either naltrexone or placebo in 10 subjects with pyromania.

详细描述

The goal of the proposed study is to evaluate the efficacy and safety of naltrexone in pyromania. Ten subjects with DSM-IV pyromania will receive 8 weeks of naltrexone or placebo. The hypothesis to be tested is that naltrexone will be effective in reducing the urges to set fires patients with pyromania. The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
16 Years 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • men and women age 16-75;
  • current DSM-IV pyromania

排除标准

  • unstable medical illness or clinically significant abnormalities on prestudy laboratory tests or physical examination;
  • history of seizures;
  • myocardial infarction within 6 months;
  • current pregnancy or lactation, or inadequate contraception in women of childbearing potential;
  • clinically significant suicidality;
  • current or recent (past 3 months) DSM-IV substance abuse or dependence;
  • illegal substance within 2 weeks of study initiation;
  • initiation of psychotherapy or behavior therapy from a mental health professional within 3 months prior to study baseline;
  • initiation of a psychotropic medication within 2 months prior to study inclusion;
  • previous treatment with naltrexone; and
  • treatment with investigational medication or depot neuroleptics within 3 months, with fluoxetine within 6 weeks, or with other psychotropics within 2 weeks prior to study baseline

研究组 & 干预措施

1

Active Comparator

Naltrexone

干预措施: Naltrexone (Drug)

2

Placebo Comparator

Placebo

干预措施: Placebo (Drug)

结局指标

主要结局

Yale Brown Obsessive Compulsive Scale Modified for Pyromania (P-YBOCS)

时间窗: At each visit

次要结局

  • Pyromania Symptom Assessment Scale (P-SAS); Sheehan Disability Inventory(At each visit)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验